Dow Tells High Court Patent Definiteness Findings Require Review Under Teva
WASHINGTON, D.C. — A jury’s findings of fact subsidiary to the issue of patent definiteness require appellate review under the reasoning of Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. (135 S.Ct....To view the full article, register now.
Already a subscriber? Click here to view full article